YARGESA
As listed in the register: YARGESA 100 mg, gélule
100 mg · gélule
- Prescription only
- Active substance
- Miglustat
- Made by
- PIRAMAL CRITICAL CARE (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States6 matching products
European UnionNo exact match for this strength and form
Spain6 matching products
Canada2 matching products
Netherlands6 matching products
- Miglustat Dipharma 100 mg harde capsules 100 mg · capsule, hard
- Miglustat G.L. 100 mg harde capsules 100 mg · capsule, hard
- Miglustat GenOrph 100 mg 100 mg · capsule, hard
- Miglustat Waymade 100 mg harde capsules 100 mg · capsule, hard
- Yargesa 100 mg harde capsules 100 mg · capsule, hard
- Zavesca 100 mg · capsule, hard
Details
| Made by | PIRAMAL CRITICAL CARE (PAYS-BAS) |
|---|---|
| Active substance | Miglustat |
| Strength | 100 mg |
| Form | gélule |
| Route | orale |
| Dispensing (as stated by the register) | prescription hospitalière · liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/17/1176 |
| Name in the register | YARGESA 100 mg, gélule |
| Packs | 84 plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 1 gélule(s) |
| CIS | 68836272 |
| CIP13 | 3400930182338 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.